Cabot Co. (NYSE:CBT) Shares Bought by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. boosted its stake in shares of Cabot Co. (NYSE:CBT - Free Report) by 0.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 710,608 shares of the specialty chemicals company's stock after acquiring an additional 3,175 shares during the quarter. Charles Schwab Investment Management Inc. owned about 1.31% of Cabot worth $64,886,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. First Horizon Advisors Inc. grew its position in Cabot by 22.0% in the 3rd quarter. First Horizon Advisors Inc. now owns 650 shares of the specialty chemicals company's stock valued at $73,000 after buying an additional 117 shares during the last quarter. GAMMA Investing LLC raised its holdings in Cabot by 10.7% during the fourth quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company's stock worth $123,000 after purchasing an additional 130 shares in the last quarter. Moran Wealth Management LLC lifted its position in Cabot by 0.3% in the third quarter. Moran Wealth Management LLC now owns 62,116 shares of the specialty chemicals company's stock valued at $6,943,000 after purchasing an additional 178 shares during the period. M&T Bank Corp boosted its holdings in Cabot by 0.4% in the 3rd quarter. M&T Bank Corp now owns 50,221 shares of the specialty chemicals company's stock valued at $5,614,000 after purchasing an additional 213 shares in the last quarter. Finally, Covestor Ltd increased its position in Cabot by 35.6% during the 3rd quarter. Covestor Ltd now owns 831 shares of the specialty chemicals company's stock worth $93,000 after purchasing an additional 218 shares during the period. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Cabot Stock Up 0.6 %

Shares of CBT traded up $0.51 during midday trading on Thursday, reaching $81.63. 314,345 shares of the company were exchanged, compared to its average volume of 435,080. The company has a current ratio of 2.00, a quick ratio of 1.29 and a debt-to-equity ratio of 0.72. Cabot Co. has a 1-year low of $79.57 and a 1-year high of $117.46. The company has a market cap of $4.43 billion, a price-to-earnings ratio of 10.84, a P/E/G ratio of 0.74 and a beta of 1.21. The stock has a 50-day moving average price of $87.07 and a 200-day moving average price of $99.76.

Cabot (NYSE:CBT - Get Free Report) last issued its quarterly earnings data on Monday, February 3rd. The specialty chemicals company reported $1.76 EPS for the quarter, topping analysts' consensus estimates of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. Research analysts expect that Cabot Co. will post 7.57 earnings per share for the current year.

Cabot announced that its Board of Directors has initiated a share repurchase plan on Tuesday, December 3rd that authorizes the company to repurchase 10,000,000 outstanding shares. This repurchase authorization authorizes the specialty chemicals company to reacquire shares of its stock through open market purchases. Stock repurchase plans are generally an indication that the company's board believes its stock is undervalued.

Cabot Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Friday, February 28th will be issued a $0.43 dividend. The ex-dividend date is Friday, February 28th. This represents a $1.72 annualized dividend and a yield of 2.11%. Cabot's dividend payout ratio is presently 22.84%.

Wall Street Analyst Weigh In

CBT has been the subject of a number of recent analyst reports. StockNews.com downgraded Cabot from a "buy" rating to a "hold" rating in a report on Tuesday. Mizuho dropped their target price on Cabot from $122.00 to $110.00 and set an "outperform" rating for the company in a research note on Tuesday, January 7th. Finally, JPMorgan Chase & Co. decreased their price target on Cabot from $105.00 to $85.00 and set an "underweight" rating on the stock in a research note on Friday, February 21st. One investment analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $97.00.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.